Autoimmune diseases, such as systemic lupus erythematosus, rheumatoid arthritis, myositis, or anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, may affect multiple organ systems. Occasionally, patients deteriorate acutely requiring advanced care in an intensive care unit (ICU). In an ICU setting, mortality is estimated with scoring systems, such as APACHE or SAPSII. Since there are limited data available on their use in autoimmune diseases, with the current study, we aim to assess the usefulness of these ICU scores and analyze predictors of mortality in this particular group of patients.
Study Type
OBSERVATIONAL
Enrollment
60
No intervention
University Medical Center Göttingen
Göttingen, Germany
RECRUITINGIn-hospital mortality
Time frame: From date of admission to the ICU until the date of death from any cause assessed up to 52 weeks
Risk of renal replacement therapy
Time frame: From date of admission to the ICU until the date of event assessed up to 52 weeks
Need for catecholamines
Time frame: From date of admission to the ICU until the date of event assessed up to 52 weeks
Need for ventilation
Time frame: From date of admission to the ICU until the date of event assessed up to 52 weeks
Need for cardiopulmonary resuscitation
Time frame: From date of admission to the ICU until the date of event assessed up to 52 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.